Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: GSK

GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov

Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]

GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov
1 week ago
Share

Germany’s CureVac Raises $450m While Announcing $180.3m Deal with GSK to Partner up on mRNA-based Vaccine Co-Development, Manufacturing & Commercialization

Germany-based CureVac, the global biopharmaceutical company developing novel transformative medicines based on messenger ribonucleic acid (“mRNA), including a high potential […]

Germany’s CureVac Raises $450m While Announcing $180.3m Deal with GSK to Partner up on mRNA-based Vaccine Co-Development, Manufacturing & Commercialization
4 weeks ago
Share

Vir Biotechnology & GSK’s Candidate Monoclonal Antibody Candidate Enters NIH-Sponsored ACTIV-3 Phase 3 Study: First Dosing

A San Francisco-based infectious disease-focused biotech called Vir Biotechnology (Nasdaq: VIR)(Vir) teamed with UK-based pharmaceutical giant GlaxoSmithKline (LSE/NSE:GSK) to inform […]

Vir Biotechnology & GSK’s Candidate Monoclonal Antibody Candidate Enters NIH-Sponsored ACTIV-3 Phase 3 Study: First Dosing
2 months ago
Share

Clinical Trials and Research Roundup | Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?

  Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen?A group calling […]

Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?
3 months ago
Share

GSK & Vir Biotechnology Commence Phase 2/3 Monoclonal Antibody Targeting COVID-19 Patients: Compete Against Regeneron & Lilly

Publicly traded Vir Biotechnology (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced the first patient was dosed in a Phase […]

GSK & Vir Biotechnology Commence Phase 23 Monoclonal Antibody Targeting COVID-19 Patients Compete Against Regeneron & Lilly
6 months ago
Share

GlaxoSmithKline Vaccine Division Allegedly Raided by Korean Authorities

Korean prosecutors have raided GlaxoSmithKline’s (GSK) vaccine division offices according to inside reporting. Although not public, speculation centers on an […]

GlaxoSmithKline Vaccine Division Allegedly Raised in Korean Authorities
7 months ago
Share

Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration: Finished Good Projected for 14+ Months Away

European pharmaceutical giants recently inked a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from […]

Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration Finished Good Projected for 14+ Months Away
11 months ago
Share

GSK Injects $250m into Vir in Collaborative Pact to Develop COVID-19 Treatments

Leveraging its capital, global reach, and functional genomics expertise, GlaxoSmithKline will inject $250 million into Vir Biotechnology, and its proprietary […]

GSK Injects $250m into Vir in Collaborative Pact to Develop COVID-19 Treatments
11 months ago
Share

GSK Taps UC Berkeley’s CRISPR Expertise to Accelerate Drug Development

GlaxoSmithKline (GSK) announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will […]

CRISPR Collaboration
2 years ago
Share

Adverse Event: GSK’s Belimumab Increased Risk of Serious Psychiatric Events Seen in Clinical Trials

The UK government reported that GSK’s Belimumab (Benlysta) have revealed in clinical trials to show an increased risk of depression, […]

Psychiatric
2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.